ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE | A040608 | MIKART LLC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Lachman Consultant Services Inc FDA-2015-P-2344 · 6 docket documents Lachman Consultant Services Inc. filed this petition on behalf of a client requesting that the FDA declare oxycodone and acetaminophen tablets in dosage strengths of 3.75 mg/300 mg and 8.75 mg/300 mg are suitable for review under an Abbreviated New Drug Application pursuant to section 505(j) of the | Other | 2015-07-14 | Withdrawn | Lachman Consultant Services Inc |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.